Stay updated with breaking news from Eric Widera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine to prescribe that has been proven to slow the loss of memory and ability to do daily tasks that Alzheimer’s brings.
Results of an 18-month trial led by US pharmaceutical producer Eli Lilly have shown its new Alzheimer's drug can delay the progression of the disease by up to 35.1 percent.
Eli Lilly Co. said it applied for full US approval of its Alzheimer s disease drug that s expected to compete with Eisai Co. s Leqembi as the US dru...
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening. Patients given monthly infusions of Eli Lilly and Co.'s donanemab declined about four to seven months more
Bringing Taiwan to the World and the World to Taiwan